Cancer Cell Research (Online ISSN: 2161-2609)
Current Issue
Vol.4 No.15
Article: Prrx1 enhanced the migration ability of breast cancer cell by initiating epithelial-mesenchymal Transition
by Wenjuan Wang, Zhidong Lv, Zhaochuan Yang, Peihong Zhou, Jiaojiao Dong, Funian Li
Cancer Cell Research 2017 4(15) 362-367; published online 27 April 2017
Abstract:
To study the effect of paired related homoeobox1 (Prrx1) on
the epithelial-mesenchymal transition (EMT) and migration
ability of breast cancer cells. Breast cancer cell lines
(including BT-474, ZR-75-1 and Mccoy’s 5A) were filtrated by
Real-time PCR to obtain the cells with the lowest expression
of Prrx1. Then the cells were transfected with Prrx1
over-expression letiviral vectors. Then the phenotype
changes of the cells were observed after the infection was
verified to be performed through Real-time PCR. The
expression of Twist protein was tested by Western blot. At
last, the effect of Prrx1 on the migration ability of the
breast cancer cell was determined by Transwell assay.
Mccoy’s 5A cells were screened to be the lowest Prrx1
expression cells in the three kinds of breast cancer cells.
Then the Mccoy’s 5A cells were transfected by letiviral
vectors to be Prrx1 over-expressing. We observed that the
morphology of these cells changed from polygon to long
spindle appearance. The real-time PCR results showed that
the expression of Prrx1, E-adherin and Vimentin was 225.80,
0.55, and 4.20 times compared with groups without
transfection respectively (p<0.05). Transwell assay showed
that the number of the migration cells in over-expression
group (72.64±5.32) was higher than both non-treated group
(39.52±3.87) and lentiviral vectors group (42.35±4.11)
(p<0.05), while the difference between the two control
groups were not statistically significant (p>0.05). Prrx1
up-regulation up-regulation can prompt EMT of breast cancer
cells and enhance their migration ability.
Open Access Download (free) PDF
Article: Inhibition of HGF- ASODN in Breast Cancer and its influence on cell proliferation
by Youfeng Guo, Huijuan Hong, Ke Kuang, Zhao Yuan, Jianming Wang
Cancer Cell Research 2017 4(15) 368-373; published online 27 May 2017
Abstract:
Oligodeoxynucleotide (ASODN) was synthesized and added to
breast cancer MDA-MB-231 cells to see its influence on cell
proliferation. After the transfection of HGF ASODN on the
MDA-MB-231 cells, immunocytochemical method, western blot
and RT-PCR methods were used to test the HGF, VEGF and PCNA
level. Cell proliferation was analyzed by MTT method. The
results showed that after transfection, 2-8 uM HGF ASODN. It
can inhibit expression of HGF and cell proliferation. The
inhibition effect begun at 24 hours and lasted to 96 hours.
The inhibition effect was related to the concentration. HGF
ASODN could also inhibit protein level of VEGF and PCNA.
Besides, HGF ASODN in different concentration could also
inhibit tumor growth. HGF promoting autocrine and paracrine
of IGF-I is important to breast tumor growth.
Open Access Download (free) PDF
Article: Blood supply of viable tumor area of hepatocellular carcinoma after transcatheter arterial chemoembolization
by Quan Li
Cancer Cell Research 2017 4(15) 374-378; published online 27 May 2017
Abstract: To evaluate the blood
supply of viable tumor area (VTA) of hepatocellular
carcinoma(HCC)after transcatheter arterial
chemoembolization using lipiodol (LP-TACE) by dual-phase
multislice computed tomography (MSCT)scanning.
Thirty-eight patients with 55 HCCs after LP-TACE
treatment were examined by plain scanning and hepatic
dual-phase MSCT. The performance of VTA on plain
scanning and the enhancement patterns on dynamic
contrast-enhanced scanning were observed. In
contrast-enhanced CT scans, the blood supply of VTA was
classified into four types: arterial blood supply,
portal blood supply, arterial together with portal blood
supply and poor blood supply. Atthe same time, the
attribution of portal venous blood supply to VTA was
compared with that before LP-TACE. The VTA appear as a
hypoattenuation lesion on unenhanced images, and the CT
value of VTA was (37.71±7.78) Hu. In contrast-enhanced
CT scans, the blood supply of VTA was classified into
four types: arterial blood supply (29 cases), portal
blood supply (2 cases), arterial together with portal
blood supply (22 cases) and poor blood supply (4 cases).
The attribution of portal venous blood supply to VTA was
significantly increased after LP-TACE. Arterial blood
supply and arterial together with portal blood supply
are the two main types of the blood supply with VTA. The
attribution of portal venous blood supply to VTA was
significantly increased after LP-TACE.
Open Access Download (free) PDF
Article: Liver cirrhosis with chylous hydrothorax and ascites: a case report and literature review
by Zhengwei Leng, Zhao Yang, Songlin Hou, Xiaoqiong Li, Yunfeng Xiao,
Sisi Wang, Lu Yang, Guansheng Huang, Jiali Li, Jinrong Xia, Zhengru Chen,
Siyu Li, Zhonghui Zhou, Jinghuang Chen, Xia qinghua, Tao kaixiong
Cancer Cell Research 2017 4(15) 378-381; published online 27 May 2017
Abstract: To study the clinical
manifestations, pathogenesis, and treatment of liver
cirrhosis with chylous hydrothorax and ascites. Methods:
A case of liver cirrhosis with chylous hydrothorax and
ascites was reported and the related literature was
reviewed. Results: The patient was hospitalized due to
massive ascites. Paracentesis and a low-fat diet were
effective. Diuretics, liver protection-therapy, and
somatostatin were performed. Twenty-eight days later,
the patient was asymptomatic without recurrent disease
at follow-up three months on. Conclusions: Liver
cirrhosis with chylous hydrothorax and ascites is rare
in clinic patients who have been diagnosed with liver
cirrhosis with chylous hydrothorax and ascites exhibits
rapid progression and poor prognosis. Low fat and high
protein diet should be considered. Diuresis, liver
protection-therapy, and the use of somatostatin were
performed. The surgery should be performed if necessary.
Open Access Download (free) PDF